Technical information
Manufacturer
IDORSIA PHARMACEUTICALS FRANCE SAS
Presentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
LVDkPCpHm9DwyHpV
Listen
